An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques.
about
Targeting IRE1 with small molecules counteracts progression of atherosclerosis.New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.The walking dead: macrophage inflammation and death in atherosclerosis.Eating the Dead to Keep Atherosclerosis at Bay.Specialized pro-resolving mediators in cardiovascular diseases.Coronary Atherosclerotic Vulnerable Plaque: Current PerspectivesStructural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.Programming and memory dynamics of innate leukocytes during tissue homeostasis and inflammation.Cell Death in the Vessel Wall: The Good, the Bad, the Ugly.13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis.Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function.MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.Proresolving Lipid Mediators Restore Balance to the Vulnerable Plaque.Novel mechanism of regulation of the 5-lipoxygenase/leukotriene B4 pathway by high-density lipoprotein in macrophages.Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications.Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity.Mechanism of Chronic Stress-induced Reduced Atherosclerotic Medial Area and Increased Plaque Instability in Rabbit Models of Chronic Stress.Monocyte-Macrophages and T Cells in Atherosclerosis.CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.Inhibition of 5-lipoxygenase alleviates graft-versus-host disease.Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases.Lipidomics unveils the complexity of the lipidome in metabolic diseases.2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular Mechanisms in the Progression of Atherosclerosis.Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis.Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease.Bioactive Lipids and Chronic Inflammation: Managing the Fire Within.Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increases Systemic Inflammation and Cardiovascular Disease.Plasma n-3 and n-6 Fatty Acids Are Differentially Related to Carotid Plaque and Its Progression: The Multi-Ethnic Study of Atherosclerosis.Δ-5 Fatty Acid Desaturase FADS1 Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators.Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.Resolvin D1 blocks H2O2-mediated inhibitory crosstalk between SHP2 and PP2A and suppresses endothelial-monocyte interactions.Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease.New maresin conjugates in tissue regeneration pathway counters leukotriene D4-stimulated vascular responses.[Atherothrombosis : Novel therapeutic strategies].Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines.CD36 Shunts Eicosanoid Metabolism to Repress CD14 Licensed Interleukin-1β Release and Inflammation.PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function.Annexins in Translational Research: Hidden Treasures to Be Found.
P2860
Q37682288-EE9E2702-EA27-4CE2-AF09-64801831EB6BQ38627502-41F3AAA6-0BB4-4695-84E3-0C50EEF1C018Q38681468-0B75D618-92C0-48C2-9E1E-F9D59916C0BAQ39088075-8A47CFF0-5EDC-42F4-B72A-DDF028278380Q39109119-18D0E8B6-8BE6-46DC-B214-0406CE77E5B6Q39134393-569A2F21-EF0C-4DCB-89EA-2F1D67B65C9BQ39160278-8E8DAA4D-9D00-4DF6-8621-BFD30F676009Q39185397-36765A20-1115-46AB-AE08-2B34802353F0Q39197238-4F60713A-8F75-4114-BB6E-367EEC1CABA5Q39286818-3EB23389-A30F-4821-B096-EED46084C995Q39388843-B8C00456-4B02-4E9F-ACB9-9764E2F23A4AQ40971881-3544E4A2-88D5-42EE-BE85-F818C5EFFE0BQ41905666-BFB53887-AC28-47CE-B210-D622E928233EQ42001768-0C5D8755-2F57-4CBB-B3CC-95189FEE54DFQ42367800-386B82E1-A625-47E8-9BD1-CA275BB83FC3Q42374930-756DEC53-A46A-49BF-847E-7906A319E9F9Q45064553-02D03243-A51D-42E4-977B-9EE115C45682Q47215351-198ACE6E-B9F8-4C5D-AC9A-1492584B6C5CQ47559124-4A4B4139-3280-48FA-BEFC-98E2A7DCD2F3Q47632654-F5F2C049-AD4B-4116-9A11-2AC0CF8EFF8BQ47708298-BDAF4C3D-D8C2-4E5E-8208-927A2451D0A9Q47744316-31A0B88B-C5AD-4908-BD65-12B0B2DE5572Q47979606-A491DE86-5C56-4799-A3A2-518F26B92865Q48157430-A901FBA3-FBD7-4219-9D82-D7BD374D5AA5Q48507796-03F68C78-82A1-4C98-9C75-B55CC08C075CQ49318594-BFA4DF1C-0927-4075-B83B-960C074883D4Q49506046-435617F4-1F8A-4B23-AED4-B522CD509EB1Q49679435-22F8DD3D-3A35-4EC1-BB93-0A194FA47FC1Q50043689-FC11D9F8-AA40-40E8-B44A-C0BFC282D0B6Q50077478-A2447E02-0F6D-4724-9466-E097115D6565Q50091983-2F055B3E-B4CE-4845-92BB-CBA027124C1CQ50129587-7320E0F1-4DE2-45FF-995E-BB8F3B4C5281Q50169256-66E56919-0518-445E-BF9C-88D5EC89EB1BQ52680904-F36AE042-F6A3-4BEE-B0C3-FF137DFD6565Q52681249-B4E2B06E-FD06-4040-A624-7BD1FA27F7DBQ52752595-61EB9475-FDB8-4E33-9792-001089BE0F43Q55057811-ABB174B4-7C66-49B0-94F6-8B2D1CFF6E34Q55128945-464886B8-AE8D-4A71-8602-911A68EBE61DQ55514888-67EC9335-7798-4DBD-8F89-E828310AC076Q55714697-A7FADAFB-D2F4-4CA3-8452-231C6737C678
P2860
An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An imbalance between specializ ...... ty of atherosclerotic plaques.
@en
An imbalance between specializ ...... ty of atherosclerotic plaques.
@nl
type
label
An imbalance between specializ ...... ty of atherosclerotic plaques.
@en
An imbalance between specializ ...... ty of atherosclerotic plaques.
@nl
prefLabel
An imbalance between specializ ...... ty of atherosclerotic plaques.
@en
An imbalance between specializ ...... ty of atherosclerotic plaques.
@nl
P2093
P2860
P356
P1476
An imbalance between specializ ...... ty of atherosclerotic plaques.
@en
P2093
Bernhard Dorweiler
David M Jones
Eric J Heyer
Gabrielle Fredman
George Kuriakose
Jason Hellmann
Jonathan D Proto
Matthew Spite
Robert Solomon
P2860
P2888
P356
10.1038/NCOMMS12859
P407
P577
2016-09-23T00:00:00Z